[mstock id="73007" asset="anvs"] FDA Allows Annovis Bio To Proceed With Phase 3 Study Of Buntanetap In Parkinson's Disease https://www.nasdaq.com/articles/fda-allows-annovis-bio-to-proceed-with-phase-3-study-of-buntanetap-in-parkinsons-disease